Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

10.18
Delayed Data
As of 4:00pm ET
 +0.35 / +3.56%
Today’s Change
6.17
Today|||52-Week Range
22.66
-17.84%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close9.83
Today’s open10.01
Day’s range9.92 - 10.48
Volume185,914
Average volume (3 months)125,512
Market cap$289.3M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-14.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.64

Competitors

 Today’s
change
Today’s
% change
NLNKNewLink Genetics Cor...+0.88+8.84%
PGNXProgenics Pharmaceut...+0.18+4.43%
VTAEVitae Pharmaceutical...+0.63+6.05%
AKBAAkebia Therapeutics ...+0.43+5.94%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs